Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 4, 2001, Pages 377-384

  Jernström, Helena ^a,b   Deal, Cheir ^c   Wilkin, Françoise ^c   Chu, William ^a   Tao, Yuzhen ^d   Majeed, Noreen ^d   Hudson, Thomas ^e   Narod, Steven A ^a   Pollak, Michael ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MONTREAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; DRUG USE; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREMENOPAUSE; PROMOTER REGIONS (GENETICS); REFERENCE VALUES;

EID: 0034894561     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors
2. Normal growth and development in the absence of hepatic insulin-like growth factor I
3. The ratio between serum levels of insulin-like growth factor (IGF)-1 and the IGF binding proteins (IGFBP)-1, 2 and 3 decreases with age in healthy adults and is increased in acromegalic patients
4. Serum insulin-like growth factor I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index
5. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-I, IGFBP-2, age, sex, body mass index, and pubertal maturation
6. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
7. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
8. Prospective study of plasma levels of insulin-like growth factor I, insulin-like growth factor binding protein-3 and colorectal cancer risk among men
9. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
10. Insulin-like growth factor physiology and cancer risk
11. Cell proliferation in carcinogenesis
12. Increased cell division as a cause of human cancer
13. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3
14. Insulin-like growth factor-I comparisons in healthy twin children
15. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-1 gene: Implications for genetic studies of bone mineral density
16. Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives
17. A switch from oral (2 mg/day) to transdermal (50 μg/day) 17β-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency
18. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like- growth factor-I, insulin-like growth factor binding protein (IGFBP)-I, and IGFBP-3 levels
19. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle
20. Serum levels of insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles
21. Racial variation in insulin-like growth factor-I and binding protein-3 concentrations in middle-age men
22. Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer
23. Breast cancer among young U.S. women in relation to oral contraception use